TrialThe Journal of antimicrobial chemotherapy2024

Human bronchopulmonary disposition and plasma pharmacokinetics of oral bemnifosbuvir (AT-527), an experimental guanosine nucleotide prodrug for COVID-19.

Xiao-Jian Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.